Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CD 349

Known as: CD-349 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Effects of CD-349, a novel 1,4-dihydro-pyridine, and other calcium antagonists on membrane potentials in spontaneously beating… Expand
1993
1993
We have synthesized new 1,4-dihydropyridine derivatives having nitrooxyalkylester moieties at the 3- and 5-positions in order to… Expand
1992
1992
We investigated the effects of CD-349, a dihydropyridine derivative, on isoproterenol (Iso)-induced relaxation in rabbit aorta… Expand
1992
1992
Summary: Serotonin (5-HT 0.1 and 0.3 µg/kg) was injected as a bolus into the renal artery of anesthetized dogs. Renal blood flow… Expand
1991
1991
Summary: We investigated the effects of nitroglycerin (NTG), atrial natriuretic peptide (ANP), and CD-349 on phorbol dibutyrate… Expand
1991
1991
We examined the calcium antagonistic action of CD-349, a dihydropyridine derivative, on goat cardiac Purkinje fibers using the… Expand
1990
1990
Summary: The effects of a Ca2+ entry blocker CD-349 and an intracellular Ca2+ release inhibitor TMB-8 on renal vasoconstriction… Expand
1989
1989
The effects of 2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (CD-349) and… Expand
1988
1988
The binding to a Ca-channel of a novel 1,4-dihydropyridine (DHP) Ca-antagonist, 2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3… Expand
1987
1987
CD-349 (2-nitratopropyl 3-nitratopropyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) inhibited the… Expand